Status:
RECRUITING
Micronerves in Dupuytren and the Impact of Its Dissection on Recurrence
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Dupuytren's Disease
Eligibility:
All Genders
18+ years
Brief Summary
Dupuytren disease (DD) is a highly prevalent disabling hand disease. Spontaneous fibrosis nodules and strands in the palms of the hand cause finger contractures in disturbing positions and movement re...
Detailed Description
Dupuytren disease (DD) is a highly prevalent disabling hand disease. Spontaneous fibrosis nodules and strands in the palms of the hand cause finger contractures in disturbing positions and movement re...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Participants eligible for inclusion in this study must meet all of the following criteria:
- The participant or his/her legally authorized representative voluntary signed the informed consent prior to the first assessment
- Participants are ≥ 18 years and diagnosed with primary/recurrent Dupuytren disease
- Included patients are eligible for microfasciectomy
- Exclusion criteria:
- Participants eligible for this study must not meet any of the following criteria:
- Patients \< 18 years
- Patient included in an interventional trial with an investigational medicinal product
- Patients with cognitive impairments, severe rheumatic disease and neurological disorders leading to flexion deformities of the fingers
Exclusion
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06142929
Start Date
January 1 2024
End Date
January 1 2026
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universitaire Ziekenhuizen KU Leuven
Leuven, Vlaams-Brabant, Belgium, 3000